RGS6 Activators
The chemical class denoted as RGS6 Activators encompasses a diverse range of compounds selected for their potential to modulate the activity of Regulator of G Protein Signaling 6 (RGS6), a protein encoded by the RGS6 gene. While direct activators for RGS6 are not explicitly identified, these compounds interact with intricate signaling pathways, primarily G protein signaling, offering insights into potential mechanisms for influencing RGS6 activity. Activators of this class involve stimulating adenylate cyclase, leading to an increase in intracellular cyclic AMP (cAMP) levels. Elevated cAMP levels can activate protein kinase A (PKA), initiating phosphorylation events that may modulate RGS6 activity. This suggests a potential regulatory role for forskolin in the G protein signaling pathways where RGS6 operates.
Additionally, activators represent another facet of RGS6 activation. Activators may promote RGS6 by disrupting its interaction with Gα subunits, consequently relieving the inhibitory effect of RGS6 on G protein signaling. This interference allows for sustained G protein activity and potentially enhances downstream cellular responses, providing another avenue for the modulation of RGS6 function. The chemical class of RGS6 Activators showcases a spectrum of compounds with diverse mechanisms of action, from influencing intracellular signaling cascades to disrupting protein-protein interactions. These compounds offer valuable tools for probing the regulatory role of RGS6 in cellular processes governed by G protein signaling, providing a foundation for understanding the intricate dynamics of this signaling pathway and the potential for targeted modulation of RGS6 activity in relevant cellular contexts.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a diterpene, may activate RGS6 by stimulating adenylate cyclase and increasing intracellular cAMP levels. Elevated cAMP levels can activate protein kinase A (PKA), leading to phosphorylation events that may modulate RGS6 activity, influencing its role in G protein signaling pathways. | ||||||
Pilocarpine | 92-13-7 | sc-479256 | 100 mg | $255.00 | 1 | |
Pilocarpine, an alkaloid, may activate RGS6 by interacting with muscarinic acetylcholine receptors. Activation of these receptors can modulate G protein signaling pathways, and by extension, influence RGS6 activity. Pilocarpine's impact on muscarinic receptors may result in altered G protein signaling dynamics, potentially activating RGS6 in the process. | ||||||
Mastoparan | 72093-21-1 | sc-200831 | 1 mg | $99.00 | ||
Mastoparan, a peptide toxin, can potentially activate RGS6 by interacting with G proteins. By mimicking the action of G protein-coupled receptors, mastoparan may lead to increased G protein activity, consequently influencing RGS6 function. The peptide's interaction with G proteins could result in the activation of RGS6 in cellular contexts governed by G protein signaling. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Prostaglandin E1 (PGE1), a prostaglandin, may activate RGS6 through its influence on G protein-coupled receptors (GPCRs). PGE1 can bind to and activate certain GPCRs, initiating downstream signaling cascades. The activation of GPCRs by PGE1 can potentially modulate RGS6 activity, affecting its role in regulating G protein signaling pathways. | ||||||
Dihydrocapsaicin | 19408-84-5 | sc-202578 sc-202578A | 10 mg 50 mg | $52.00 $156.00 | 1 | |
Dihydrocapsaicin, a capsaicinoid, may activate RGS6 by interacting with transient receptor potential cation channel subfamily V member 1 (TRPV1). Activation of TRPV1 by dihydrocapsaicin can lead to intracellular signaling events, potentially influencing RGS6 activity in the context of TRPV1-mediated G protein signaling pathways. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gallein is a small molecule that may activate RGS6 by disrupting its interaction with Gα subunits. By interfering with this interaction, gallein can potentially relieve the inhibitory effect of RGS6 on G protein signaling, allowing for sustained G protein activity and modulating cellular responses governed by G protein-coupled receptors. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a synthetic catecholamine, may activate RGS6 by interacting with β-adrenergic receptors. Stimulation of these receptors can initiate G protein signaling pathways, potentially influencing RGS6 activity. Isoproterenol's impact on β-adrenergic receptors may result in altered G protein signaling dynamics, leading to the activation of RGS6 in relevant cellular contexts. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
Calcitriol, the active form of vitamin D3, may activate RGS6 by modulating vitamin D receptors. Activation of these receptors can influence G protein signaling pathways, potentially affecting RGS6 activity. Calcitriol's impact on vitamin D receptors may result in altered G protein signaling dynamics, leading to the activation of RGS6 in relevant cellular contexts. | ||||||
Arginine vasopressin | 113-79-1 | sc-507381 | 100 mg | $810.00 | ||
[Arg8]-Vasopressin, a peptide hormone, may activate RGS6 by interacting with vasopressin receptors. Activation of these receptors can initiate G protein signaling pathways, potentially influencing RGS6 activity. [Arg8]-Vasopressin's impact on vasopressin receptors may result in altered G protein signaling dynamics, leading to the activation of RGS6 in relevant cellular contexts. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a non-selective beta-adrenergic receptor antagonist, may indirectly activate RGS6 by blocking the inhibitory effect of beta-adrenergic receptors. By preventing the inhibitory signals initiated by these receptors, propranolol may allow for sustained G protein activity, potentially influencing RGS6 in cellular processes governed by beta-adrenergic signaling. | ||||||